Alumis eyes late-stage lupus study despite trial miss

Alumis said on Tuesday it plans to advance its experimental drug for a type of immunity-related condition in ​a smaller subset of patients, even after the treatment failed ‌to meet the main goal of a ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。